| Ident. | Authors (with country if any) | Title |
|---|
| 000154 |
QIAN XU [Canada, République populaire de Chine] ; HONGLING GUO [Canada] ; XIAOJIE ZHANG [Canada] ; BEISHA TANG [République populaire de Chine] ; FANG CAI [Canada] ; WEIHUI ZHOU [République populaire de Chine] ; WEIHONG SONG [Canada, République populaire de Chine] | Hypoxia regulation of ATP13A2 (PARK9) gene transcription |
| 000546 |
Frank J. S. Lee [Canada] ; FANG LIU [Canada] | Genetic factors involved in the pathogenesis of Parkinson's disease |
| 000576 |
S. Potvin [Canada] ; S. Grignon [Canada] | Dopamine et douleur : une revue de littérature : Fibromyalgie |
| 000685 |
Fannie St-Gelais [Canada] ; Claudia Jomphe [Canada] ; Louis-Eric Trudeau [Canada] | The role of neurotensin in central nervous system pathophysiology : What is the evidence? |
| 000782 |
Shawn Hayley [Canada] ; Hymie Anisman [Canada] | Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: Neurochemical and molecular substrates : The role of cytokines in neurodegeneration and psychiatric conditions: Multiple mechanisms of action |
| 000809 |
Véronique Sgambato-Faure [France] ; Virginie Buggia [France] ; Frangois Gilbert [Canada] ; Daniel Levesque [Canada] ; Alim-Louis Benabid [France] ; Francois Berger [France] | Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-lnduced behavioral sensitization in dyskinetic rats |
| 000837 |
Alexander Zimprich [Allemagne] ; Bertram Müller-Myhsok [États-Unis] ; Matthew Farrer [États-Unis] ; Petra Leitner [Allemagne] ; Manu Sharma [Allemagne] ; Mary Hulihan [États-Unis] ; Paul Lockhart [États-Unis] ; Audrey Strongosky [États-Unis] ; Jennifer Kachergus [États-Unis] ; Donald B. Calne [Canada] ; Jon Stoessl [Canada] ; Ryan J. Uitti [États-Unis] ; Ronald F. Pfeiffer [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Nikolaus Homann [Autriche] ; Erwin Ott [Autriche] ; Karoline Wenzel [Autriche] ; Friedrich Asmus [Allemagne] ; John Hardy [Royaume-Uni] ; Zbigniew Wszolek [États-Unis] ; Thomas Gasser [Allemagne] | The PARK8 locus in autosomal dominant Parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval |
| 000872 |
Chong S. Lee [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Lisa Kuramoto [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Lack of Regional selectivity during the progression of Parkinson disease: Implications for pathogenesis |
| 000903 |
Ajit Kumar [Canada] ; Sharanpal Mann [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] ; Chong S. Lee [Canada] | [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease |
| 000921 |
K. Fuxe [Suède] ; L. F. Agnati [Italie] ; K. Jacobsen [Canada] ; J. Hillion [États-Unis] ; M. Canals [Espagne] ; M. Torvinen [Suède] ; B. Tinner-Staines [Canada] ; W. Staines [Canada] ; D. Rosin [États-Unis] ; A. Terasmaa [Suède] ; P. Popoli [Italie] ; G. Leo [Italie] ; V. Vergoni [Italie] ; C. Lluis [Espagne] ; F. Ciruela [Espagne] ; R. Franco [Espagne] ; S. Ferre [États-Unis] | Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease |
| 000931 |
William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] | Pallidal neuronal activity: Implications for models of dystonia |
| 000935 |
Paul S. Fitzmaurice [Canada] ; LEE ANG [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease |
| 000961 |
A. Jon Stoessl [Canada] ; Raul De La Fuente-Fernandez [Canada] | Dopamine receptors in Parkinson's disease: Imaging studies |
| 000974 |
Stephen J. Kish [Canada] | Biochemistry of Parkinson's disease: Is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? |
| 000977 |
David K. Simon [États-Unis] ; Jennifer Friedman ; Xandra O. Breakefield [États-Unis] ; Joseph Jankovic [États-Unis] ; Mitchell F. Brin [États-Unis] ; John Provias [Canada] ; Susan B. Bressman [États-Unis] ; Michael E. Charness [États-Unis] ; Daniel Tarsy [États-Unis] ; Donald R. Johns [États-Unis] ; Mark A. Tarnopolsky [Canada] | A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia |
| 000992 |
T. A. Greenwood [États-Unis] ; M. Alexander [États-Unis] ; P. E. Keck [États-Unis] ; S. Mcelroy [États-Unis] ; A. D. Sadovnick [Canada] ; R. A. Remick [Canada] ; S. H. Jr Shaw [États-Unis] ; J. R. Kelsoe [États-Unis] | Segmental linkage disequilibrium within the dopamine transporter gene |
| 000995 |
Andrew J. Thompson [Royaume-Uni] ; Colin J. Barrow [Canada] | Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and Prion diseases |
| 000A13 |
Frédéric Calon [Canada] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias |
| 000A18 |
Stefan Müller-Lissner [Allemagne] | General geriatrics and gastroenterology: constipation and faecal incontinence |
| 000A43 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Othman Ghribi [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Alteration of glutamate receptors in the striatum of dyskinetic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment |
| 000A44 |
J. M. Woulfe [Canada] ; R. Duke [Canada] ; J. M. Middeldorp [Pays-Bas] ; S. Stevens [Pays-Bas] ; M. Vervoort [Pays-Bas] ; M. Hashimoto [États-Unis] ; E. Masliah [États-Unis] ; P. Chan ; D. A. Di Monte [États-Unis] ; J. W. Langston [États-Unis] ; G. Petzinger [États-Unis] ; H. Hoogendoorn [Canada] ; D. G. Munoz [Canada, Espagne] | Absence of elevated anti-α-synuclein and anti-EBV latent membrane protein antibodies in PD |
| 000A48 |
| Parkinson's disease |
| 000A54 |
Kurt A. Jellinger [Autriche] | The pathology of Parkinson's disease |
| 000A57 |
Andrzej Friedman [Pologne] ; Jolanta Galazka-Friedman [Pologne] | The current state of free radicals in Parkinson's disease: Nigral iron as a trigger of oxidative stress |
| 000A68 |
Andreas Hartmann [France] ; Etienne C. Hirsch [France] | Parkinson's disease: The apoptosis hypothesis revisited |
| 000A79 |
Thomas Gasser [Allemagne] | Molecular genetics of Parkinson's disease |
| 000A88 |
Patrick L. Mcgeer [Canada] ; Koji Yasojima [Canada] ; Edith G. Mcgeer [Canada] | Inflammation in Parkinson's disease |
| 000A95 |
Kirk A. Frey [États-Unis] ; Robert A. Koeppe ; Michael R. Kilbourn | Imaging the vesicular monoamine transporter |
| 000A97 |
Kevin St. P. Mcnaught [Royaume-Uni] ; Moonhee Lee [Royaume-Uni] ; Dong-Hoon Hyun [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Glial cells and abnormal protein handling in the pathogenesis of Parkinson's disease |
| 000B04 |
Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon] ; Tohru Kitada [Japon] ; Hiroto Matsumine [Japon] ; Hideo Mori [Japon] ; Hideki Shimura [Japon] ; Shinichiro Kubo [Japon] ; Hirokazu Kobayashi [Japon] ; Shuichi Asakawa [Japon] ; Shinsei Minoshima [Japon] ; Nobuyoshi Shimizu [Japon] | Familial Parkinson's disease: α-Synuclein and parkin |
| 000B06 |
André Parent [Canada] ; Martine Cossette [Canada] | Extrastriatal dopamine and Parkinson's disease |
| 000B16 |
Oleh Hornykiewicz [Autriche] | Dopamine and Parkinson's disease: A personal view of the past, the present, and the future |
| 000B30 |
A. H. V. Schapira [Royaume-Uni] | Causes of neuronal death in Parkinson's disease |
| 000B39 |
Mitsuo Takahashi [Japon] ; Tatsuo Yamada [Japon] | A possible role of influenza A virus infection for Parkinson's disease |
| 000B47 |
P. A. Pahapill [Canada] ; A. M. Lozano [Canada] | The pedunculopontine nucleus and Parkinson's disease |
| 000B50 |
James N. Oak [Canada] ; John Oldenhof [Canada] ; Hubert H. M. Van Tol [Canada] | The dopamine D4 receptor : one decade of research |
| 000B94 |
C. S. Lee [Canada] ; M. A. Cenci [Suède] ; M. Schulzer [Canada] ; A. Björklund [Suède] | Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease |
| 000C01 |
J. F. Marsden [Royaume-Uni] ; P. Ashby [Canada] ; P. Limousin-Dowsey [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; P. Brown [Royaume-Uni] | Coherence between cerebellar thalamus, cortex and muscle in man: Cerebellar thalamus interactions |
| 000C05 |
C. Schwab [Canada] ; P. L. Mcgeer [Canada] | Aβ42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and Pick bodies |
| 000C66 |
D. Frankel [Canada] ; H. M. Schipper [Canada] | Cysteamine pretreatment of the astroglial substratum (mitochondrial iron sequestration) enhances PC12 cell vulnerability to oxidative injury |
| 000C83 |
E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | The future use of complement inhibitors for the treatment of neurological diseases |
| 000D04 |
C. F. Lippa [États-Unis] ; H. Fujiwara [Japon] ; D. M. A. Mann [Royaume-Uni] ; B. Giasson [États-Unis] ; M. Baba [Japon] ; M. L. Schmidt [États-Unis] ; L. E. Nee [États-Unis] ; B. O'Connell [États-Unis] ; D. A. Pollen [États-Unis] ; P. S. George-Hyslop [Canada] ; B. Ghetti [États-Unis] ; D. Nochlin [États-Unis] ; T. D. Bird [États-Unis] ; N. J. Cairns [Royaume-Uni] ; V. M.-Y. Lee [États-Unis] ; T. Iwatsubo [Japon] ; J. Q. Trojanowski [États-Unis] | Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes |
| 000D31 |
A. Takeda [États-Unis, Japon] ; M. Mallory [États-Unis] ; M. Sundsmo [États-Unis] ; W. Honer [Canada] ; L. Hansen [États-Unis] ; E. Masliah [États-Unis] | Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders |
| 000D86 |
W. D. Hutchison [Canada] ; R. Levy [Canada] ; J. O. Dostrovsky [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] | Effects of apomorphine on globus pallidus neurons in parkinsonian patients |
| 000D88 |
C. Schwab [Canada] ; J. C. Steele ; P. L. Mcgeer [Canada] | Dystrophic neurites are associated with early stage extracellular neurofibrillary tangles in the parkinsonism-dementia complex of Guam |
| 000D96 |
R. Kumar [Canada] ; A. E. Lang [Canada] | Coexistence of tics and parkinsonism : Evidence for non-dopaminergic mechanisms in tic pathogenesis |
| 000D99 |
C. Schwab [Canada] ; J. C. Steele [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles |
| 000E35 |
C. Bergeron [Canada] ; C. Petrunka ; L. Weyer | Copper/zinc superoxide dismutase expression in the human central nervous system : correlation with selective neuronal vulnerability |
| 000E57 |
C. S. Lee [Canada] ; M. Schulzer ; E. Mak ; J. P. Hammerstad ; S. Calne ; D. B. Calne | Patterns of asymmetry do not change over the course of idiopathic parkinsonism : implications for pathogenesis |
| 000E89 |
D. A. Figlewicz [Canada] ; R. M. Garruto ; A. Krizus [Canada] ; R. Yanagihara ; G. A. Rouleau [Canada] | The Cu/Zn superoxide dismutase gene in ALS and Parkinsonism-dementia of Guam |
| 000E99 |
F. J. G. Vingerhoets [Canada] ; B. J. Snow [Canada] ; J. W. Tetrud ; J. W. Langston ; M. Schulzer [Canada] ; D. B. Calne [Canada] | Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions |
| 000F08 |
D. B. Calne [Canada] | Is idiopathic parkinsonism the consequence of an event or a process ? |
| 000F13 |
W. D. Hutchison [Canada] ; A. M. Lozano ; K. D. Davis [Canada] ; J. A. Saint-Cyr ; A. E. Lang ; J. O. Dostrovsky | Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients |
| 000F26 |
M. S. Pollanen [Canada] ; D. W. Dickson ; C. Bergeron | Pathology and biology of the Lewy body |
| 000F55 |
J. Poirier [Canada] ; C. Thiffault | Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease ? |
| 000F65 |
D. B. Calne [Canada] | The free radical hypothesis in idiopathic Parkinsonism : evidence against it |
| 000F74 |
J. Kalra [Canada] ; A. H. Rajput ; S. V. Mantha ; K. Prasad | Serum antioxidant enzyme activity in Parkinson's disease |
| 001051 |
B. J. Snow ; R. F. Peppard ; M. Guttman ; J. Okada ; W. Martin ; J. Steele ; A. Eisen ; G. Carr ; B. Schoenberg ; D. Calne | Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in lytico-bodig : the amyotrophic lateral sclerosis-Parkinsonism-dementia complex of guam |
| 001079 |
T. L. Perry ; C. Bergeron ; A. J. Biro ; S. Hansen | β-N-methylamino-L-alanine: chronic oral administration is not neurotoxic to mice |
| 001114 |
P. L. Mcgeer ; S. Itagaki ; H. Akiyama ; E. G. Mcgeer | Rate of cell death in parkinsonism indicates active neuropathological process |
